Lumexa Imaging Holdings, Inc. Common Stock (LMRI) vs Vor Biopharma Inc. (VOR)
A side-by-side comparison of Lumexa Imaging Holdings, Inc. Common Stock and Vor Biopharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LMRI
Lumexa Imaging Holdings, Inc. Common Stock
$10.65HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
VOR
Vor Biopharma Inc.
$18.36HealthcareDelayed quote: Oct 6, 2026, 3:30 PM EDT
Total return — LMRI vs VOR
growth of $100 · dividends reinvested · last 1yLMRI -41.8% (-41.8%/yr)VOR +53.2% (+53.2%/yr)VOR compounded faster over this window
LMRI VOR
LMRI vs VOR: by the numbers
- •LMRI is the larger company ($1.02B vs $995M market cap).
- •Both run net losses; VOR's is the smaller (0.00% vs -2.66% net margin).
Metrics side by side
Valuation
| Metric | LMRI | VOR |
|---|---|---|
| Forward P/E | 16.58 | N/A |
| P/S ratio | 0.98 | N/A |
| P/B ratio | 1.66 | N/A |
| EV / EBITDA | 27.98 | N/A |
| FCF yield | 3.11% | N/A |
Profitability
| Metric | LMRI | VOR |
|---|---|---|
| Gross margin | 11.80% | 0.00% |
| Operating margin | 1.38% | 0.00% |
| Net margin | -2.66% | 0.00% |
| ROE | -4.51% | N/A |
| ROIC | 0.86% | -32.24% |
Growth (annualized)
| Metric | LMRI | VOR |
|---|---|---|
| Total return CAGR (5Y) | N/A | -42.54% |
Go deeper
Dig into the metrics
Lumexa Imaging Holdings, Inc. Common Stock ROEVor Biopharma ROELumexa Imaging Holdings, Inc. Common Stock operating marginVor Biopharma operating marginLumexa Imaging Holdings, Inc. Common Stock revenue growthVor Biopharma revenue growthLumexa Imaging Holdings, Inc. Common Stock free cash flowVor Biopharma free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.